TW
Twist Bioscience
TWST·NASDAQS San Francisco CAFounded 20131,100 employees
Mid CapbiotechPublicOncology
Platform: Synth Bio DNA
Market Cap
$3B
All Drugs
3
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (TWST)
Loading TWST stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| TWS-2496 | TWS-2496 | Phase 2/3 | 2 | CD47 | MesoAngelman | ||
| Zorinesiran | TWS-3026 | Phase 1/2 | 1 | BCL-2 | IgAN | ||
| Capimavacamten | TWS-3672 | Phase 1 | 2 | TIGIT | CRCPsoriasis |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)